View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
June 19, 2022

Europe’s medical devices industry saw a rise of 12.50% in cross border deal activity during May 2022

By Carmen

Europe’s medical devices industry saw a rise of 12.50% in cross border deal activity during May 2022, when compared with the last 12-month average, led by Straumann’s $138.06m acquisition of SunshineSmile, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 27 medical devices industry cross border deals worth $356.7m were announced for the region in May 2022, against the 12-month average of 24 deals.

Of all the deal types, M&A saw most activity in May 2022 with 14 transactions, representing a 51.9% share for the region.

In second place was venture financing with nine deals, followed by private equity deals with four transactions, respectively capturing a 33.3% and 14.8% share of the overall cross border deal activity for the month.

In terms of value of cross border deals, M&A was the leading category in Europe’s medical devices industry with $177.75m, while venture financing and private equity deals totalled $153.5m and $25.5m, respectively.

Europe medical devices industry cross border deals in May 2022: Top deals

The top five medical devices cross border deals accounted for 80.3% of the overall value during May 2022.

The combined value of the top five medical devices cross border deals stood at $286.51m, against the overall value of $356.7m recorded for the month.

The top five medical devices industry cross border deals of May 2022 tracked by GlobalData were:

1) Straumann $138.06m acquisition deal with SunshineSmile

2) The $75.34m venture financing of Diabeloop by Innovacom,LBO France and Terumo

3) AlbionVC,Athyrium Capital Management and DNV Group $25.5m private equity deal with uMotif

4) The $24.68m acquisition of Rigenerand by Evotec

5) Evonik Venture Capital,Fountain Healthcare Partners,LSP Health Economics Fund,Orchestra BioMed and Panakes Partners $22.92m venture financing deal with Vivasure Medical

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article: ,
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network